Fluid Management Market By Product (Infusion Therapy Systems, Renal Systems), By Application (Urology, Cardiology, Orthopedic/Osteology, Neurology, Oncology, Gastroenterology), By End-users, By Regions - Global Market Insights 2020 - 2025

Introduction

Revenues in the fluid management market are projected to grow at a robust rate between 2021 and 2031.

Sensing the opportunities, key players are relying on innovations, sustainability, and product development to gain a major share in the market. 

For instance, in March 2021, Ecolab Inc., the global leader in water, hygiene, and infection prevention solutions and services, announced the launch of an enhanced version of its Smart Water Navigator. 

Smart Water Navigator aims at making businesses understand the value of water in their operations and take necessary actions to achieve corporate water goals.

In addition to this, in December 2020, Medline announced two new healthcare sustainability programs. 

The programs, a Green Product Portfolio, and a Sustainable Packaging Lab will help hospitals reducing the production waste coming out of their facilities.

Global Fluid Management Market Insights

The rise in incidences of End Stage Renal Disease (ESRD) has pushed up demand for dialysis products, thus augmenting the global fluid management market.

The market is poised to be leveraged moderately at a CAGR of 5.3% during the forecast period (2020-2025).

A rising ageing population, which has led to increased chronic urological diseases, shall also leverage the market.

Cerebrospinal fluid management is another area which is enticing leading manufacturers to innovate and come out with new treatment solutions in the field of neurology.

The COVID-19 pandemic is anticipated to provide possible growth opportunities for the market with regard to treating severely ill patients. Fluid management in burns treatment is rapidly gaining traction.

Application Insights

According to the British Kidney Patients Association, more than two million people undergo dialysis therapy across the word annually. This is attributed to rising incidences of chronic kidney diseases.

This rising number of dialysis procedures is poised to leverage the urology fluid management segment. It is anticipated to capture nearly two-fifths of the global fluid management market, expanding at a CAGR of 5.3%.

Trailing behind is the cardiology segment, poised to capture nearly a quarter of the global fluid management market. Rising morbidities due to cardiac complications is a major growth driver for the cardiology segment.

The World Health Organization estimates that more than 17 million people die due to cardiac diseases.

Out of these, more than three-quarters of the deaths occur in economically poor regions. Projected CAGR for the cardiology segment is pegged at 5.9%.

Product Insights

The infusion therapy standards of practice is anticipated to capture a major chunk of the global fluid management market, amounting to more than half.

The demand for intravenous administration of fluids and medicines to chronically ill and dehydrated patients who don’t respond to oral therapy is anticipated to leverage the infusion therapy market. Projections indicate a modest CAGR of 5.3% during the forecast period.

However, the renal products segment is catching up, expanding at a CAGR of 5.5% throughout the forecast period. Increasing pool of dialysis patients shall contribute to increased usage of renal products.

This is because kidney patients require fluid management via dialysis procedures such as hemodialysis and peritoneal dialysis.

Renal products manufacturers are innovating on renal disposables and ancillaries, saline solutions & concentrates and dialysis accessories.

Regional Analysis

North America is foreseen to capture the bulk of the global fluid management market.

Increasing demand for smart pumps, rising number of launches of next-generation infusion devices and growing prevalence of lifestyle diseases are prophesied to leverage market share.

Infusion-therapy segment shall account for more than half of the North American fluid management market.

As a whole, North America shall constitute one-third of the global fluid management market, expanding at a CAGR of 4.0%.

Asia-Pacific is anticipated to demonstrate a positive growth outlook in the global fluid management market.

High demand for intravenous fluids due to high prevalence of infectious diseases such as diarrhea, typhoid, malaria and cholera as well as increasing number of patients with ESRD is anticipated to bolster the Asia-Pacific fluid management market.

A healthy CAGR of 7.0% is projected for the region, with the region set to expand 1.5x in the forecast period.

Key Expansion Strategy

Baxter Healthcare manufactures the Spectrum IQ Infusion System. This is an intelligently designed device to simplify EMR integration.

It includes facilities like on-screen barcode technology with scan prompts, auto-programming workflows and feature sets to help drive consistent compliance and intuitive workflows to confirm IV infusion tasks.

Likewise, Braun Holding GmbH & Co. manufactures EXCEL IV Containers and Partial Additive Bags (PAB). The EXCEL IV containers are biologically inert and are suitable for storing important medications.

These are devoid of PVC, which otherwise would react with the medicine to release di (2-ethylhexyl) phthalate (DEHP) present in the PVC coating.

COVID-19 Impact Insights

In the midst of the COVID-19 pandemic, fluid management is anticipated to find useful application for offering hemodynamic support to critically ill patients.

Fluid management is considered important to reduce pulmonary edema. Fluid conservative therapy is recommended to achieve a negative fluid balance of 500 mL to 1 liter per day.

Administration of crystalloids for acute resuscitation of patients is highly recommended.

Leading market players in the market are leaving no stone unturned to ensure mitigation of the deadly pandemic.

To this end, Baxter Healthcare is concentrating on ensuring a steady supply of its products. The company proactively manages inventory levels, stock levels in warehouses and transportation options.

The company is also providing financial support to multiple groups addressing patient needs. It does so through its Baxter International Foundation. Dialysis supplies are also being augmented in order to cater to renal disorder patients.

Stryker Corporation, another market player, has released its Emergency Relief Bed, a limited-release medical bed to support critical needs during the pandemic.

The bed features a 30-degree head of bed angle to accommodate patients in respiratory distress. It also features low height and an attached IV pole.

Analyst’s Viewpoint:

The global fluid management market is prophesied to expand significantly throughout the forecast period. Rising prevalence of end stage renal disease and the recent COVID-19 pandemic are key growth levers. Demand for intravenous fluid administration is propelling the infusion therapy segment, whereas increasing pool of dialysis patients is augmenting the renal products segment.

Key Questions Answered in Fact.MR’s Fluid management market Report

• What is the fluid management market size?
• How has fluid management market grown over the years?
• Who are the leading exporters for fluid management market?
• What is the market share of top fluid management market players?
• What are the key trends impacting fluid management market growth?
• What is the North America fluid management market Outlook?
• How will sales of fluid management market grow in Europe?
• How will demand for fluid management market grow in Japan and South Korea?

Market Segmentation

Fact.MR has studied the detailed segmentation on the basis of product, application, end-users, and key regions.

• By Product :

  • Infusion Therapy Systems:

    • Infusion Devices
    • IV Access Devices
    • IV Solutions & Products

  • Renal Systems:

    • In-center Hemodialysis Products
    • Home Hemodialysis Products (HHD)
    • Peritoneal Dialysis
    • Products
    • Acute Dialysis Products

• By Application :

  • Urology
  • Cardiology
  • Orthopedic/Osteology
  • Neurology
  • Oncology
  • Gastroenterology
  • Others (Anesthesiology, Bronchology, Dentistry, Otology and Gynecology)

• By End-users :

  • Hospitals
  • Clinics
  • Dialysis Centers
  • Home Care Settings
  • Others

• By Key Regions :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”